Expert Review of Neurotherapeutics

News in brief
pp. 587-589(3)

Donepezil in the treatment of patients with Alzheimer's disease
pp. 591-598(8)
Author: Tsuno, Norifumi

Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block
pp. 599-608(10)
Authors: Hogg, Rosemary MG; Mirakhur, Rajinder K

Buprenorphine for opioid dependence
pp. 609-616(8)
Author: Ling, Walter

Metabolic links between diabetes and Alzheimer's disease
pp. 617-630(14)
Authors: Maher, Pamela A; Schubert, David R

Copper in Alzheimer's disease: too much or too little?
pp. 631-637(7)
Authors: Quinn, Joseph F; Crane, Susanne; Harris, Christopher; Wadsworth, Teri L

Pediatric stroke guidelines: where will these take future research and treatment options for childhood stroke?
pp. 639-648(10)
Author: Ganesan, Vijeya

The triptans
pp. 649-659(11)
Authors: Bigal, Marcelo E; Krymchantowski, Abouch V; Hargreaves, Richard

Secretase inhibitors and modulators for Alzheimer's disease treatment
pp. 661-679(19)
Author: Tomita, Taisuke

Calcium dyshomeostasis and neurotoxicity of Alzheimer's β-amyloid protein
pp. 681-693(13)
Authors: Kawahara, Masahiro; Negishi-Kato, Midori; Sadakane, Yutaka

Cholesterol-modifying strategies for Alzheimer's disease
pp. 695-709(15)
Authors: Solomon, Alina; Kivipelto, Miia

Post-stroke pain
pp. 711-721(11)
Author: Kim, Jong S

Transition from acute to chronic postsurgical pain: risk factors and protective factors
pp. 723-744(22)
Authors: Katz, Joel; Seltzer, Ze''ev

Transition from acute to chronic postsurgical pain: risk factors and protective factors
pp. 723-744(22)
Authors: Katz, Joel; Seltzer, Ze'ev

Pain catastrophizing: a critical review
pp. 745-758(14)
Authors: Quartana, Phillip J; Campbell, Claudia M; Edwards, Robert R

Brain-evoked potentials as a tool for diagnosing neuropathic pain
pp. 759-771(13)
Authors: Pazzaglia, Costanza; Valeriani, Massimiliano

Acknowledgements
pp. 779-779(1)